- Parties: The appellant was Galderma Canada Inc. The respondent was the Attorney General of Canada.

- Subject Matter: This appeal sought to quash and/or set aside a judgment dismissing the appellant's judicial review application challenging the Patented Medicine Prices Review Board's decision requiring the appellant to file pricing information for Differin for the period between Jan. 1, 2010 and Mar. 14, 2016. This case is ongoing.

- Date: The hearing was set on Nov. 7, 2024.

- Venue: This was a federal case before the Federal Court of Appeal.

- Amount: No financial award was specified.